Furthermore, in the context of lung cancer the subtype of KRAS-induced tumors (i.e., adenocarcinoma vs squamous carcinoma) is regulated by activation of the NOTCH signaling pathway and expression of SOX2 [38]. Here, KRAS is linked to adenocarcinoma.